Rocket Pharmaceuticals Q3 EPS $(0.38) Up From $(0.40) YoY

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.38) per share. This is a 5 percent increase over losses of $(0.4) per share from the same period last year.

Benzinga · 11/07/2019 13:18

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.38) per share. This is a 5 percent increase over losses of $(0.4) per share from the same period last year.